Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
misiu143's Profile
Displaying 2651-2700 of 4584 result(s).
CYDY CytoDyn Inc
08/06/2019 10:52:37 AM
This I am sure ,IMO this will becom
CYDY CytoDyn Inc
08/06/2019 10:40:14 AM
Yes HCIT , Couple hrs ago I send an
CYDY CytoDyn Inc
08/06/2019 8:08:30 AM
Yes , of course , I will post here
CYDY CytoDyn Inc
08/06/2019 7:48:21 AM
That what I am hoping , but with FD
CYDY CytoDyn Inc
08/06/2019 7:33:27 AM
What worry me is that if they neede
CYDY CytoDyn Inc
08/05/2019 5:24:41 PM
IMO very good for Tweet or Facebook
CYDY CytoDyn Inc
08/05/2019 2:36:13 PM
Trding , great , Please add what we
CYDY CytoDyn Inc
08/05/2019 1:54:10 PM
I try to add what we know about CCR (4)
CYDY CytoDyn Inc
08/03/2019 2:20:17 PM
Yes , now I know ...
CYDY CytoDyn Inc
08/03/2019 2:19:38 PM
Yes , and as we did talk in the pas
CYDY CytoDyn Inc
08/03/2019 1:37:39 PM
Schingel just replied to Ohm...very
CYDY CytoDyn Inc
08/03/2019 10:34:39 AM
We find study in Miami , not founde
CYDY CytoDyn Inc
08/03/2019 9:40:07 AM
Thank you , I will try to check tha
CYDY CytoDyn Inc
08/03/2019 9:35:27 AM
Nt2 - yes , and not only that , low (1)
CYDY CytoDyn Inc
08/03/2019 8:55:51 AM
Talking about studies , my uncle wh
CYDY CytoDyn Inc
08/03/2019 3:48:27 AM
Not a good statistics , I believe t
CYDY CytoDyn Inc
08/03/2019 3:39:31 AM
Yes this is a plan , I don’t know
CYDY CytoDyn Inc
08/03/2019 3:32:17 AM
But it show here only about 3 month
CYDY CytoDyn Inc
08/03/2019 2:57:20 AM
Yes , this is from March 2018 , Dr
CYDY CytoDyn Inc
08/02/2019 10:26:01 PM
But if pre-clinical study will be v
CYDY CytoDyn Inc
08/02/2019 9:56:49 PM
I am not sure what will happen here
CYDY CytoDyn Inc
08/02/2019 9:12:06 PM
I believe Dr NP said with Truvada f
CYDY CytoDyn Inc
08/02/2019 8:06:34 PM
Yes and because this is one of the
CYDY CytoDyn Inc
08/02/2019 7:57:01 PM
You are right , statistics in USA a
CYDY CytoDyn Inc
08/02/2019 3:10:59 PM
I agree Lorbas , he is very committ
CYDY CytoDyn Inc
08/02/2019 2:57:57 PM
I believe that Marek is doing very (4)
CYDY CytoDyn Inc
08/02/2019 2:38:38 PM
If Leronlimab is stopping angiogene (1)
CYDY CytoDyn Inc
08/02/2019 2:27:38 PM
Today interview ..... This is inter (3)
CYDY CytoDyn Inc
08/02/2019 11:39:28 AM
And not Suvorov , different connect
CYDY CytoDyn Inc
08/02/2019 10:44:39 AM
That is my feeling...LOL
CYDY CytoDyn Inc
08/02/2019 10:40:19 AM
I have a feeling that 2 days old po
CYDY CytoDyn Inc
08/02/2019 9:52:24 AM
Yes , something probably is little
CYDY CytoDyn Inc
08/02/2019 9:34:46 AM
Pre-clinical , in vivo. And he was
CYDY CytoDyn Inc
08/02/2019 9:25:30 AM
I am just little surprise , I thoug
CYDY CytoDyn Inc
08/01/2019 9:23:45 PM
Yes , I forgot , we had " stunning
CYDY CytoDyn Inc
08/01/2019 9:15:57 PM
About one or two years ago Dr NP sa
CYDY CytoDyn Inc
08/01/2019 4:44:54 PM
This is very good , thank you Trdin
CYDY CytoDyn Inc
08/01/2019 12:39:35 PM
PS , and there is also polarization (1)
CYDY CytoDyn Inc
08/01/2019 10:47:57 AM
Few things are regulated by CCR5 in (1)
CYDY CytoDyn Inc
07/31/2019 12:58:49 PM
Fortuno ...OK ...LOL ..I do underst
CYDY CytoDyn Inc
07/31/2019 10:52:18 AM
Other companies will be paying for
CYDY CytoDyn Inc
07/31/2019 10:36:21 AM
This will not happened before very
CYDY CytoDyn Inc
07/31/2019 10:22:46 AM
I agree , that was a short study ,
CYDY CytoDyn Inc
07/31/2019 9:40:41 AM
Zuess , - one drug from Australian
CYDY CytoDyn Inc
07/31/2019 9:22:29 AM
there is a big difference with Emer
CYDY CytoDyn Inc
07/31/2019 9:15:34 AM
Manipulators like that I have the l
CYDY CytoDyn Inc
07/31/2019 9:13:58 AM
Agree 100 % , I think many don't re
CYDY CytoDyn Inc
07/31/2019 8:46:21 AM
Yes , I agree , she is more honest
CYDY CytoDyn Inc
07/31/2019 8:37:29 AM
This Grip it person I took off igno
CYDY CytoDyn Inc
07/31/2019 8:27:36 AM
So many very important and interest
Go to page:
  • << First
  • < Previous
  • 53
  • 54
  • Next >

Recent Articles

  • Spyre Therapeutics Unveils Promising Data at Major Gastro Event
  • Spyre Therapeutics Prepares for UEGW 2025 with New Data Release
  • Ripple CTO Steps Back as Bitcoin and Dogecoin Make Waves
  • LifeMD Investors Alert: Securities Fraud Class Action Update
  • Major Automakers Respond to EV Credit Changes in 2024
  • Shenzhen Futian Fashion Day Showcases Global Fashion Vision
  • Electric Vehicles in the Spotlight: Tesla and Nissan News
  • ATRenew's Recognition as an Earthshot Prize Finalist in 2025
  • Mark Cuban's Essential Tips for Startup Founders on Funding
  • MOG Digitech Partners with Luckyins Technology to Innovate Insurtech
  • Exploring the Future of Trust in Web3: Cregis and Sumsub Event
  • Economic Insights: Government Shutdowns, Gold Trends, and AI Impact
  • California Drivers Celebrate New Unionization Rights
  • Tesla Shareholders Rally Against Musk's Massive Compensation Plan
  • Exploring New Frontiers with Planet Classroom's Latest Shorts
  • OpenAI Expands Consumer Offerings with Strategic Acquisition
  • Online Marriages Revolutionized: MarryFromHome.com Launch
  • Absolutaris Base Unveils Philanthropy Strategy for Global Impact
  • Navigating the AI Landscape: Insights from John Chambers on Market Volatility
  • Exploring OpenAI's Global Expansion and AI Infrastructure Plans
  • Empowering Educators: The Call for Resources and Support
  • Court Upholds Birthright Citizenship Against Executive Order
  • Jeff Bezos Envisions Space-Based Data Centers for Future Needs
  • Legal Battle Over National Guard Deployment in Portland Escalates
  • Strategic Moves of Beta Technologies in Electric Aviation Market
  • Urgent Search for Missing Teen Michael Kocabay: Community Efforts
  • Exploring Visceral Fat's Role in Endometrial Cancer Progression
  • Protect Your Investment: Join the Dow Inc. Class Action Today
  • CTO Realty Growth, Inc. Class Action Deadline Approaches Soon
  • Sam Altman's Perspective on AI and Farming as a Backup Plan
  • Star Princess Embarks on Its Inaugural Voyage from Spain
  • Unicoin, Inc. Investors: Explore Securities Class Action Options
  • How Taylor Swift’s Strategy Can Inspire Your Success Journey
  • Barbara Corcoran's Key Traits for Entrepreneurial Success
  • Investors Urged to Participate in Cytokinetics Action for Rights
  • Urgent Action for PubMatic Investors: Class Action Details
  • Public Opinions Shift on Economic Policies Amid Turmoil
  • Lawsuit Against Tesla Highlights Concerns Over Cybertruck Safety
  • Cytokinetics Investors Urged to Seek Legal Counsel Soon
  • Innovative AI Agent Infrastructure Secures Funding for Growth
  • BOE O•SPACE Celebrates Eastern Aesthetics in Milan Exhibition
  • Important Class Action Alert for Fortinet, Inc. Investors
  • Class Action Lawsuit Aims to Hold KinderCare Accountable
  • Bitcoin Approaches Historic High as Investors Seek Stability
  • Kiyosaki Questions Buffett's Shift to Gold and Silver Investments
  • Yutong's Innovative EV Technology Makes Waves at Busworld Europe
  • Bragar Eagel & Squire Encourages Investors to Act Now
  • Lantheus Holdings Faces Class Action: Key Information for Investors
  • Investors Alert: Class Action Rights for VFC, CYTK, NX, and RICK
  • Exploring Exclusive Industries That Cater to the Wealthy Elite
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site